Inogen Inc (INGN)

$11.11 0.28 (2.59%)

16:00 EDT INGN Stock Quote Delayed 30 Minutes

Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich… or Broke.

By Josh Enomoto, InvestorPlace Contributor May 18, 2023

While lesser-known enterprises present viability risks, those wanting to swing for the fences should seek small-cap stocks to buy.

10 Triple-A Stocks to Buy in February

The 10 Best Stocks to Buy Right Now

7 A-Rated Stocks to Buy for the Second Half of 2018

More Articles

Volume:

Previous Close -

Market Cap 256.88M

PE Ratio -2.83

EPS -3.93

Volume (Avg. Vol.) 141,853

Day's Range $10.79 - $11.17

52-Week Range $10.57 - $32.01

Dividend & Yield N/A (N/A)

INGN Stock Predictions, Articles, and Inogen Inc News

From InvestorPlace
From the Web

3 Medical Device Stocks to Brave Policy Uncertainty (MASI, IDXX, INGN)

By Zacks Investment Research Mar 17, 2017

These medical device stocks are primed to take advantage of the lifting of some rules and regulations out of Washington

4 Big Winners of Trump’s Healthcare Plan

By Zacks Investment Research Mar 10, 2017

The new healthcare legislation has its own sets of winners and losers, and we've identified these healthcare stocks to buy

10 Health Care Equipment & Supplies Stocks to Buy Now

By Portfolio Grader Nov 28, 2016

The grades of 10 Health Care Equipment & Supplies stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

11 Health Care Equipment & Supplies Stocks to Buy Now

By Portfolio Grader Oct 17, 2016

The grades of 11 Health Care Equipment & Supplies stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

7 Healthcare Stocks That Are Fit as a Fiddle

By Louis Navellier, Editor, Growth Investor Apr 8, 2016

We're entering a period of slow growth, not just domestically, but globally. Healthcare is a great place to be right now.

INGN: A Breath of Fresh Air

By Richard Band Oct 23, 2015

This niche player has cornered the market in an important healthcare sector.

3 Strong Stocks to Buy in the Healthcare Sector

By Louis Navellier, Editor, Growth Investor Jun 1, 2015

Inogen (INGN), AMAG Pharmaceuticals (AMAG) and Centene (CNC) continue to be characterized by strong forecasted earnings and sales.

3 Biotech Stocks in the News

By Louis Navellier, Editor, Growth Investor May 4, 2015

Depomed Inc (NASDAQ:DEPO), Horizon Pharma PLC (NASDAQ:HZNP) and Inogen Inc (NASDAQ:INGN) have made announcements recently that investors should be aware of.

6 Health-Related Stocks to Buy This Spring

By Louis Navellier, Editor, Growth Investor Mar 20, 2015

In particular, stocks in drug manufacturing, biotechnology and medical appliances have been having a decently strong 2015 so far.

Inogen GAAP EPS of -$0.88 misses by $0.10, revenue of $72.2M misses by $2.48M (NASDAQ:INGN)

From Seeking Alpha May 4, 2023

Inogen press release (NASDAQ:INGN): Q1 GAAP EPS of -$0.88 misses by $0.10.Revenue of $72.2M (-10.2% Y/Y) misses by $2.48M.

Inogen Non-GAAP EPS of -$0.57 beats by $0.08, revenue of $88.09M misses by $1.61M (NASDAQ:INGN)

From Seeking Alpha Feb 23, 2023

Inogen press release (INGN): Q4 Non-GAAP EPS of -$0.57 beats by $0.08.Revenue of $88.09M (+15.3% Y/Y) misses by $1.61M.

INGN stock lower as William Blair downgrades on macro headwinds (NASDAQ:INGN)

From Seeking Alpha Jan 17, 2023

The shares of Inogen Inc. (INGN) fell in the morning hours Tuesday after William Blair downgraded it to Market Perform from Outperform, citing macro headwinds. Read the full story here.

Inogen

From Seeking Alpha Jan 10, 2023

Inogen (INGN) estimates Q4 total revenue to be in the range of $87.5M to $88.5M, representing Y/Y growth of 14.5% to 15.8%, vs consensus of $89.48M

Inogen (INGN) Receives a Hold from Stifel Nicolaus

From TipRanks Nov 8, 2022

Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Inogen (INGN – Research Report) on November 4 and set a price target of $24.00. The compan...

Inogen (INGN) Gets a Buy from Needham

From TipRanks Nov 2, 2022

In a report released today, Michael Matson from Needham maintained a Buy rating on Inogen (INGN – Research Report), with a price target of $36.00. The company...